Structural studies of receptor binding by cholera toxin mutants

被引:79
作者
Merritt, EA
Sarfaty, S
Jobling, MG
Chang, T
Holmes, RK
Hirst, TR
Hol, WGJ
机构
[1] UNIV WASHINGTON,DEPT BIOL STRUCT,SEATTLE,WA 98195
[2] UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195
[3] UNIV COLORADO,SCH MED,DEPT MICROBIOL,DENVER,CO 80262
[4] UNIV BRISTOL,DEPT PATHOL & MICROBIOL,BRISTOL BS8 1TV,AVON,ENGLAND
基金
英国惠康基金;
关键词
cholera toxin; heat-labile enterotoxin; oligosaccharide; sugar-binding; X-ray crystallography;
D O I
10.1002/pro.5560060716
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The wide range of receptor binding affinities reported to result from mutations at residue Gly 33 of the cholera toxin B-pentamer (CTB) has been most puzzling. For instance, introduction of an aspartate at this position abolishes receptor binding, whereas substitution by arginine retains receptor affinity despite the larger side chain, We now report the structure determination and 2.3-Angstrom refinement of the CTB mutant Gly 33 --> Arg complexed with the G(M1) oligosaccharide, as well as the 2.2-Angstrom refinement of a Gly 33 --> Asp mutant of the closely related Escherichia coli heat-labile enterotoxin B-pentamer (LTB). Two of the five receptor binding sites in the Gly 33 --> Arg CTB mutant are occupied by bound G(M1) oligosaccharide; two other sites are involved in a reciprocal toxin:toxin interaction; one site is unoccupied. We further report a higher resolution (2.0 Angstrom) determination and refinement of the wild-type CTB:G(M1) oligosaccharide complex in which all five oligosaccharides are seen to be bound in essentially identical conformations, Saccharide conformation and binding interactions are very similar in both the CTB wild-type and Gly 33 --> Arg mutant complexes. The protein conformation observed for the binding-deficient Gly 33 --> Asp mutant of LTB does not differ substantially from that seen in the toxin:saccharide complexes. The critical nature of the side chain of residue 33 is apparently due to a limited range of subtle rearrangements available to both the toxin and the saccharide to accommodate receptor binding. The intermolecular interactions seen in the CTB (Gly 33 --> Arg) complex with oligosaccharide suggest that the affinity of this mutant for the receptor is close to the self-affinity corresponding to the toxin:toxin binding interaction that has now been observed in crystal structures of three CTB mutants.
引用
收藏
页码:1516 / 1528
页数:13
相关论文
共 50 条
  • [21] Hetero-multivalent binding of cholera toxin subunit B with glycolipid mixtures
    Krishnan, Pratik
    Singla, Akshi
    Lee, Chin-An
    Weatherston, Joshua D.
    Worstell, Nolan C.
    Wu, Hung-Jen
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2017, 160 : 281 - 288
  • [22] Structural studies on HLA-G: Implications for ligand and receptor binding
    Clements, Craig S.
    Kjer-Nielsen, Lars
    McCluskey, James
    Rossjohn, Jamie
    HUMAN IMMUNOLOGY, 2007, 68 (04) : 220 - 226
  • [23] The different inhibiting effect of cholera toxin on two leukemia cell lines does not correlate with their toxin binding capacity
    Giuliani, A
    Calappi, E
    Mineo, E
    Neri, MG
    Gallina, A
    Pessina, A
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 152 (02) : 103 - 112
  • [24] Cholera toxin phage: structural and functional diversity between Vibrio cholerae biotypes
    Safa, Ashrafus
    Jime, Jinath Sultana
    Shahel, Farishta
    AIMS MICROBIOLOGY, 2020, 6 (02): : 144 - 151
  • [25] Destruction of cholera toxin receptor on HeLa cell membrane using microbial endoglycoceramidase
    Yamamoto, K
    Nagano, T
    Kumagai, H
    Okamoto, Y
    Otani, S
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 328 (01) : 51 - 56
  • [26] Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera
    Das, Soumita
    Angsantikul, Pavimol
    Le, Christine
    Bao, Denny
    Miyamoto, Yukiko
    Gao, Weiwei
    Zhang, Liangfang
    Eckmann, Lars
    PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (02):
  • [27] Vibrio cholerae:: Cholera toxin
    Vanden Broeck, Davy
    Horvath, Caroline
    De Wolf, Marc J. S.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (10) : 1771 - 1775
  • [28] Preclinical pharmacology of cholera toxin
    Reid, JM
    Benson, JW
    Viallet, J
    Ames, MM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 36 (02) : 115 - 120
  • [29] Carbohydrate inhibitors of cholera toxin
    Kumar, Vajinder
    Turnbull, W. Bruce
    BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2018, 14 : 484 - 498
  • [30] Tetra-versus Pentavalent Inhibitors of Cholera Toxin
    Fu, Ou
    Pukin, Aliaksei V.
    van Ufford, H. C. Quarles
    Branson, Thomas R.
    Thies-Weesie, Dominique M. E.
    Turnbull, W. Bruce
    Visser, Gerben M.
    Pieters, Roland J.
    CHEMISTRYOPEN, 2015, 4 (04): : 471 - 477